Form 4: Entrada Therapeutics Insider Sells Shares

Sentiment:

Insider Transaction (Form 4)


MPM BioVentures 2014, L.P. and 9 others reported changes in beneficial ownership of Entrada Therapeutics, Inc. common stock on September 1, 2026.

Summary

  • Open-market sale: disposed of 29,088 Common Stock at $7.06 ($205,361) on September 1, 2026; holds 4,202,346 after (Indirect).
  • Open-market sale: disposed of 25,131 Common Stock at $7.19 ($180,692) on September 2, 2026; holds 4,177,215 after (Indirect).
  • Open-market sale: disposed of 32,263 Common Stock at $7.17 ($231,326) on September 3, 2026; holds 4,144,952 after (Indirect).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $617,379 of stock on the open market.

Insider Transactions

MPM BioVentures 2014, L.P. — 10% owner

Luke Evnin — 10% owner

Ansbert Gadicke — 10% owner

Todd Foley — 10% owner

MPM BioVentures 2014 (B), L.P. — 10% owner

MPM Asset Management Investors BV2014 LLC — 10% owner

MPM BioVentures 2014 LLC — 10% owner

MPM BioVentures 2014 GP LLC — 10% owner

Mpm Bioventures 2018 (B), L.P. — 10% owner

Mpm Asset Management Investors Bv2018 Llc — 10% owner

DateTransactionSecuritySharesPriceValueHeld After
2026-09-01Open-market saleCommon Stock29,088$7$205.4K4,202,346
2026-09-02Open-market saleCommon Stock25,131$7$180.7K4,177,215
2026-09-03Open-market saleCommon Stock32,263$7$231.3K4,144,952

Key Dates

DateDescription
2026-09-01Open-market sale (29,088 shares)
2026-09-02Open-market sale (25,131 shares)
2026-09-03Open-market sale (32,263 shares)

Keywords

insider transaction, Form 4, TRDA, Entrada Therapeutics, Inc., bearish, MPM BioVentures 2014, L.P., Luke Evnin, Ansbert Gadicke, Todd Foley, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, Mpm Bioventures 2018 (B), L.P., Mpm Asset Management Investors Bv2018 Llc

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.